Roanoke Asset Management Corp Abbott Laboratories Transaction History

Roanoke Asset Management Corp

$318 Million
Q3 2024

A detailed history of Roanoke Asset Management Corp transactions in Abbott Laboratories stock. As of the latest transaction made, Roanoke Asset Management Corp holds 53,108 shares of ABT stock, worth $6.25 Million. This represents 1.9% of its overall portfolio holdings.

Number of Shares

53,108

Previous 50,911 4.32%

Holding current value

$6.25 Million

Previous $5.29 Million 14.46%

% of portfolio

1.9%

Previous 1.75%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	BUY	$100.07 - $118.13 $219,853 - $259,531	2,197 Added 4.32%	53,108 $6.06 Million
Q2 2024 Aug 14, 2024	BUY	$100.73 - $112.44 $561,670 - $626,965	5,576 Added 12.3%	50,911 $5.29 Million
Q1 2024 May 08, 2024	BUY	$109.52 - $120.96 $215,973 - $238,533	1,972 Added 4.55%	45,335 $5.15 Million
Q4 2023 Feb 08, 2024	BUY	$90.19 - $110.4 $3,337 - $4,084	37 Added 0.09%	43,363 $4.77 Million
Q3 2023 Nov 15, 2023	SELL	$95.53 - $114.62 $9,361 - $11,232	-98 Reduced 0.23%	43,326 $4.2 Million
Q2 2023 Jul 31, 2023	BUY	$100.78 - $112.29 $201 - $224	2 Added 0.0%	43,424 $4.73 Million
Q1 2023 May 02, 2023	SELL	$96.86 - $114.01 $290 - $342	-3 Reduced 0.01%	43,422 $4.4 Million
Q4 2022 Feb 08, 2023	SELL	$95.06 - $111.52 $196,108 - $230,065	-2,063 Reduced 4.54%	43,425 $4.77 Million
Q3 2022 Nov 03, 2022	SELL	$96.76 - $112.03 $20,609 - $23,862	-213 Reduced 0.47%	45,488 $4.4 Million
Q2 2022 Aug 10, 2022	SELL	$102.07 - $123.37 $2,347 - $2,837	-23 Reduced 0.05%	45,701 $4.97 Million
Q1 2022 May 11, 2022	SELL	$114.02 - $139.04 $344,226 - $419,761	-3,019 Reduced 6.19%	45,724 $5.41 Million
Q4 2021 Feb 09, 2022	SELL	$115.53 - $141.46 $26,918 - $32,960	-233 Reduced 0.48%	48,743 $6.86 Million
Q3 2021 Nov 03, 2021	BUY	$116.66 - $129.06 $116 - $129	1 Added 0.0%	48,976 $5.79 Million
Q2 2021 Jul 28, 2021	BUY	$105.79 - $124.53 $756,398 - $890,389	7,150 Added 17.1%	48,975 $5.68 Million
Q1 2021 May 14, 2021	SELL	$108.84 - $128.23 $4,897 - $5,770	-45 Reduced 0.11%	41,825 $5.01 Million
Q4 2020 Feb 12, 2021	SELL	$105.0 - $114.42 $60,375 - $65,791	-575 Reduced 1.35%	41,870 $4.58 Million
Q3 2020 Nov 12, 2020	BUY	$91.64 - $111.29 $458 - $556	5 Added 0.01%	42,445 $4.62 Million
Q2 2020 Aug 05, 2020	SELL	$76.57 - $98.0 $275,345 - $352,408	-3,596 Reduced 7.81%	42,440 $3.88 Million
Q1 2020 May 13, 2020	SELL	$62.82 - $91.86 $16,647 - $24,342	-265 Reduced 0.57%	46,036 $3.63 Million
Q4 2019 Feb 05, 2020	SELL	$78.51 - $87.4 $783,451 - $872,164	-9,979 Reduced 17.73%	46,301 $4.02 Million
Q3 2019 Nov 01, 2019	SELL	$81.84 - $88.74 $55,242 - $59,899	-675 Reduced 1.19%	56,280 $4.71 Million
Q2 2019 Jul 19, 2019	SELL	$72.88 - $85.0 $9,110 - $10,625	-125 Reduced 0.22%	56,955 $4.79 Million
Q1 2019 Apr 29, 2019	BUY	$66.22 - $80.06 $33,110 - $40,030	500 Added 0.88%	57,080 $4.56 Million
Q4 2018 Feb 06, 2019	SELL	$65.56 - $74.27 $50,153 - $56,816	-765 Reduced 1.33%	56,580 $4.09 Million
Q3 2018 Oct 30, 2018	BUY	$60.81 - $73.36 $624,518 - $753,407	10,270 Added 21.82%	57,345 $4.21 Million
Q2 2018 Jul 25, 2018	SELL	$57.57 - $63.54 $98,732 - $108,971	-1,715 Reduced 3.52%	47,075 $2.87 Million
Q1 2018 Apr 19, 2018	SELL	$56.27 - $63.62 $36,294 - $41,034	-645 Reduced 1.3%	48,790 $2.92 Million
Q4 2017 Jan 29, 2018	SELL	$53.68 - $57.47 $130,979 - $140,226	-2,440 Reduced 4.7%	49,435 $2.82 Million
Q3 2017 Oct 20, 2017	BUY	$48.06 - $53.64 $2.49 Million - $2.78 Million	51,875	51,875 $2.77 Million

Others Institutions Holding ABT

# of Institutions

3,173

Shares Held

1.33B

Call Options Held

8.62M

Put Options Held

7.18M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $206B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Roanoke Asset Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Roanoke Asset Management Corp with notifications on news.

Account

Roanoke Asset Management Corp Abbott Laboratories Transaction History